NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









QuantX Biosciences

QuantX Biosciences

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://quantxbio.com/

Last Round

Series B

Feb 9, 2026

Total Funding Raised

$175M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

QuantX Biosciences is a biotechnology company that operates a computationally driven drug discovery platform to design and optimize oral small molecule therapeutics for immune-mediated and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

computational drug discoverydrug discoveryai drug discoverymulti-omicsprecision medicinebiomarker identificationtherapeutic target validationin silico drug discoverypatient stratificationbiotech research servicesdrug development pipelineai biotechpreclinical developmentsmall molecule discoverytechbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QuantX Biosciences Comparables

Compare QuantX Biosciences with similar companies based on industry and business-model similarity.

QuantX Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healx
84%
Valo Health
80%
BenevolentAI
78%

QuantX Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 9, 2026

Key People

Founding team and executive leadership

Yax Sun

Co-founder And Chief Technology Officer

Founding Team

QuantX Biosciences Investors

Notable investors and investment history

QuantX Biosciences investors
InvestorRounds
Creacion VenturesSeries A, Series B
OrbiMedSeries A, Series B
Sanofi VenturesSeries B
Lilly Asia VenturesSeries B
HongShan Capital Group (HSG)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 24, 2026

    Grew 24% QoQ, from 25 to 31 employees.

  • Apr 24, 2026

    Grew 27% QoQ, from 22 to 28 employees.

QuantX Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

QuantX Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QuantX Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range33
Year Founded2022
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.